Patients undergoing bowel cancer treatment at Sheffield Teaching Hospitals NHS Foundation Trust will be invited to try out ...

Despite the lack of differences, "the fact remains that DOs do not match into surgical residencies at the same rate as MDs," the researchers wrote. Indeed, they are more likely to go into primary care ...

Today we have two new segments in our "Chasing Cancer" series, and later we'll hear from Dr. Steven Rosenberg from the National Cancer Institute.

Mr. Tamberrino and Profound’s CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 – – Appointment comes as Profound continues to make final preparations ...

Mr. Tamberrino and Profound's CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 - - Appointment comes as Profound continues to make final preparations ...

The Buccaneers will tackle the NFL's best rushing attack in Week Seven but will look to build on their own recent ...

CHI St. Vincent has been recognized by U.S. News & World Report for its high performance across a number of treatment areas, ...

In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021. The market is projected to ...

Colorectal cancer is on the rise. It is the 3rd leading cause of cancer-related deaths among men and the 4th among women in the United States.

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

Mayo Clinic Platform_Accelerate has announced a strategic agreement with the Japan External Trade Organization (JETRO) to implement a two-phase ...